Inflation Continues To Rear Head At US FDA User Fees

 
• By Derrick Gingery
  
inflation
Inflation constituted the entire adjustment made for FY 2025 GDUFA fees. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from User Fees

More from Pathways & Standards